Markets:

Overview

News

Currencies

International

Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

26.60 -0.67 (-2.46%)

Streaming Delayed Price Updated: 3:21 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022

July 19, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics: Q1 Earnings Insights ↗

May 03, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated...

Via Benzinga

Fulgent Genetics Reports First Quarter 2022 Financial Results

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Why Fulgent Genetics Shares Are Trading Higher Today ↗

April 19, 2022

Via Benzinga

Recap: Fulgent Genetics Q4 Earnings ↗

February 23, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

Fulgent Genetics Announces Promotions and Leadership Updates

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Earnings Outlook For Fulgent Genetics ↗

May 02, 2022

Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Fulgent...

Via Benzinga

Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results

April 18, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022

April 18, 2022

From Fulgent Genetics, Inc.

Via Business Wire

These Are Ten Small Cap Stocks With Strong Buy Recommendations ↗

March 27, 2022

One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...

Via Talk Markets

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Fulgent Genetics Announces Strategic Investment in Spatial Genomics

February 23, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results

February 23, 2022

From Fulgent Genetics, Inc.

Via Business Wire

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022

February 14, 2022

From Fulgent Genetics, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

January 03, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave ↗

December 22, 2021

COVID testing in a parking garage in Miami on Tuesday (photo via Jordan Levin). Good Luck Getting Into A Medical Clinic A woman we know got in a car accident over the...

Via Benzinga

Corona Doom 3.0: Omicron Surge ↗

December 22, 2021

One of the beneficiaries of the COVID testing boom is Fulgent Genetics, Inc.

Via Talk Markets

5 Value Stocks In The Healthcare Sector ↗

December 20, 2021

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Is Fulgent Genetics a Good Healthcare Stock to Buy? ↗

December 08, 2021

Shares fell earlier in the November, but popped again after a robust third-quarter earnings report.

Via The Motley Fool

HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available

December 06, 2021

From Fulgent Genetics, Inc.

Via Business Wire

How Wide Is Fulgent Genetics' Moat? ↗

December 03, 2021

The genetic testing company's moat is expanding.

Via The Motley Fool

3 Stocks That Could Make You Richer in December (and Beyond) ↗

December 02, 2021

Shares of these companies are gift-wrapped for those with patience.

Via The Motley Fool

Topics Economy

The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance ↗

December 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...

Via Benzinga

Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More ↗

December 02, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ:

Via Benzinga

Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19

December 01, 2021

From Fulgent Genetics, Inc.

Via Business Wire

56 Biggest Movers From Friday ↗

November 29, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.